Dong RZ - Search Results

1

Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors.

Lu JC, Zeng HY, Sun QM, Meng QN, Huang XY, Zhang PF, Yang X, Peng R, Gao C, Wei CY, Shen YH, Cai JB, Dong RZ, Shi YH, Sun HC, Shi YG, Zhou J, Fan J, Ke AW, Yang LX, Shi GM. Lu JC, et al. Among authors: dong rz. Theranostics. 2019 Jul 9;9(16):4678-4687. doi: 10.7150/thno.36276. eCollection 2019. Theranostics. 2019. PMID: 31367249 Free PMC article.

2

Mortalin promotes cell proliferation and epithelial mesenchymal transition of intrahepatic cholangiocarcinoma cells in vitro.

Kang Q, Cai JB, Dong RZ, Liu LX, Zhang C, Zhang PF, Zou H, Xie N, Zhang L, Zhang XY, Song ZJ, Dong ZR, Hu MY, Huang XY, Zhang XW, Ke AW, Shi GM. Kang Q, et al. Among authors: dong rz, dong zr. J Clin Pathol. 2017 Aug;70(8):677-683. doi: 10.1136/jclinpath-2016-204251. Epub 2017 Jan 17. J Clin Pathol. 2017. PMID: 28096273

3

Invasive potential of hepatocellular carcinoma is enhanced by loss of selenium-binding protein 1 and subsequent upregulation of CXCR4.

Gao PT, Ding GY, Yang X, Dong RZ, Hu B, Zhu XD, Cai JB, Ji Y, Shi GM, Shen YH, Zhou J, Fan J, Sun HC, Huang C. Gao PT, et al. Among authors: dong rz. Am J Cancer Res. 2018 Jun 1;8(6):1040-1049. eCollection 2018. Am J Cancer Res. 2018. PMID: 30034941 Free PMC article.

4

Predicting overall survival of patients with hepatocellular carcinoma using a three-category method based on DNA methylation and machine learning.

Dong RZ, Yang X, Zhang XY, Gao PT, Ke AW, Sun HC, Zhou J, Fan J, Cai JB, Shi GM. Dong RZ, et al. J Cell Mol Med. 2019 May;23(5):3369-3374. doi: 10.1111/jcmm.14231. Epub 2019 Feb 19. J Cell Mol Med. 2019. PMID: 30784182 Free PMC article.

5

Lymphoid-specific helicase promotes the growth and invasion of hepatocellular carcinoma by transcriptional regulation of centromere protein F expression.

Yang X, Miao BS, Wei CY, Dong RZ, Gao PT, Zhang XY, Lu JC, Gao C, Wang XY, Sun HC, Zhou J, Fan J, Ke AW, Shi GM, Cai JB. Yang X, et al. Among authors: dong rz. Cancer Sci. 2019 Jul;110(7):2133-2144. doi: 10.1111/cas.14037. Epub 2019 May 25. Cancer Sci. 2019. PMID: 31066149 Free PMC article.

6

eIF3a mediates HIF1α-dependent glycolytic metabolism in hepatocellular carcinoma cells through translational regulation.

Miao B, Wei C, Qiao Z, Han W, Chai X, Lu J, Gao C, Dong R, Gao D, Huang C, Ke A, Zhou J, Fan J, Shi G, Lan F, Cai J. Miao B, et al. Am J Cancer Res. 2019 May 5;9(5):1079-1090. eCollection 2019. Am J Cancer Res. 2019. PMID: 31218114 Free PMC article.

7

Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma.

Cai J, Chen L, Zhang Z, Zhang X, Lu X, Liu W, Shi G, Ge Y, Gao P, Yang Y, Ke A, Xiao L, Dong R, Zhu Y, Yang X, Wang J, Zhu T, Yang D, Huang X, Sui C, Qiu S, Shen F, Sun H, Zhou W, Zhou J, Nie J, Zeng C, Stroup EK, Zhang X, Chiu BC, Lau WY, He C, Wang H, Zhang W, Fan J. Cai J, et al. Gut. 2019 Dec;68(12):2195-2205. doi: 10.1136/gutjnl-2019-318882. Epub 2019 Jul 29. Gut. 2019. PMID: 31358576 Free PMC article.

8

Mortalin stabilizes CD151-depedent tetraspanin-enriched microdomains and implicates in the progression of hepatocellular carcinoma.

Liu LX, Lu JC, Zeng HY, Cai JB, Zhang PF, Guo XJ, Huang XY, Dong RZ, Zhang C, Kang Q, Zou H, Zhang XY, Zhang L, Zhang XW, Ke AW, Shi GM. Liu LX, et al. Among authors: dong rz. J Cancer. 2019 Oct 15;10(25):6199-6206. doi: 10.7150/jca.36301. eCollection 2019. J Cancer. 2019. PMID: 31772652 Free PMC article.

9

Quantitative acetylome analysis reveals histone modifications that may predict prognosis in hepatitis B-related hepatocellular carcinoma.

Chai X, Guo J, Dong R, Yang X, Deng C, Wei C, Xu J, Han W, Lu J, Gao C, Gao D, Huang C, Ke A, Li S, Li H, Tian Y, Gu Z, Liu S, Liu H, Chen Q, Liu F, Zhou J, Fan J, Shi G, Wu F, Cai J. Chai X, et al. Clin Transl Med. 2021 Mar;11(3):e313. doi: 10.1002/ctm2.313. Clin Transl Med. 2021. PMID: 33783990 Free PMC article.

10

Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy.

Dong ZR, Cai JB, Shi GM, Yang YF, Huang XY, Zhang C, Dong RZ, Wei CY, Li T, Ke AW, Fan J. Dong ZR, et al. Among authors: dong rz. Cancer Lett. 2023 Jun 28;564:216186. doi: 10.1016/j.canlet.2023.216186. Epub 2023 Apr 25. Cancer Lett. 2023. PMID: 37105392

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page